https://orcid.org/0000-0002-4367-254X
Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Alfredo Chetta, Nicola Facciolongo, Cosimo Franco, Laura Franzini, Alessio Piraino & Carmelina Rossi. (2022) Impulse Oscillometry, Small Airways Disease, and Extra-Fine Formulations in Asthma and Chronic Obstructive Pulmonary Disease: Windows for New Opportunities. Therapeutics and Clinical Risk Management 18, pages 965-979.
Read now
Read now
Christian Gessner, Frederik Trinkmann, Sanaz Bahari Javan, Raimund Hövelmann, Valentina Bogoevska, George Georges, Elena Nudo & Carl-Peter Criée. (2022) Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 3019-3031.
Read now
Read now
Articles from other publishers (13)
Eduardo Genofre, Donna Carstens, Wilfried DeBacker, Patrick Muchmore, Reynold A. PanettieriJrJr, Kirsty Rhodes, Vivian H. Shih & Frank Trudo. (2023) The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approach. Respiratory Research 24:1.
Crossref
Crossref
Anwarul Islam Chowdhury, Md. Jamal Uddin, Tarit Kumar Baul, Jarin Akhter, Rajasree Nandi, Shyamal Karmakar & Tapan Kumar Nath. (2022) Quantifying the potential contribution of urban trees to particulate matters removal: A study in Chattogram city, Bangladesh. Journal of Cleaner Production 380, pages 135015.
Crossref
Crossref
Emanuela Resta, Giulia Scioscia, Donato Lacedonia, Carla Maria Irene Quarato, Francesco Panza, Onofrio Resta, Giorgia Lepore, Enrico Buonamico, Valentina Di Lecce, Giovanna Elisiana Carpagnano, Maria Pia Foschino Barbaro & Noemi Rossi. (2022) Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region. BMC Health Services Research 22:1.
Crossref
Crossref
Nowaf Y Alobaidi, Mohammed Almeshari, James Stockley, Robert Andrew Stockley & Elizabeth Sapey. (2022) Small airway function measured using forced expiratory flow between 25% and 75% of vital capacity and its relationship to airflow limitation in symptomatic ever-smokers: a cross-sectional study. BMJ Open Respiratory Research 9:1, pages e001385.
Crossref
Crossref
Omar S. UsmaniSimonetta BaldiSimon WarrenIlaria PanniLuca GirardelloFrançois RonyGlyn TaylorWilfried DeBackerGeorge Georges. (2022) Lung Deposition of Inhaled Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide in Healthy Volunteers and Asthma: The STORM Study. Journal of Aerosol Medicine and Pulmonary Drug Delivery 35:4, pages 179-185.
Crossref
Crossref
Lei Han, Yuning Huang, Qiang Fu, Yishu Xue, Fengming Ding & Min Zhang. (2022) Tracking the response to Pseudomonas aeruginosa infection in ozone-induced chronic obstructive pulmonary disease mouse models. Biomedicine & Pharmacotherapy 150, pages 112980.
Crossref
Crossref
Kazunori Kadota, Koichi Matsumoto, Hiromasa Uchiyama, Satoshi Tobita, Munehiro Maeda, Daisuke Maki, Yuhei Kinehara, Isao Tachibana, Tomasz R. Sosnowski & Yuichi Tozuka. (2022) In silico evaluation of particle transport and deposition in the airways of individual patients with chronic obstructive pulmonary disease. European Journal of Pharmaceutics and Biopharmaceutics 174, pages 10-19.
Crossref
Crossref
Fulvio Braido, Angelo G. Corsico, Davide Paleari, Alessio Piraino, Luca Cavalieri & Nicola Scichilone. (2022) Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution. Therapeutic Advances in Respiratory Disease 16, pages 175346662110660.
Crossref
Crossref
Nicolai Obling, Bojidar Rangelov, Vibeke Backer, John R. Hurst & Uffe Bodtger. (2022) Upper airway symptoms and Small Airways Disease in Chronic Obstructive Pulmonary Disease, COPD. Respiratory Medicine 191, pages 106710.
Crossref
Crossref
Paschalis Steiropoulos, Petros Bakakos, Elpis Hatziagorou, Paraskevi Katsaounou, Stelios Loukides, Andriana Papaioannou, Konstantinos Porpodis, Konstantinos Samaras, Argyrios Tzouvelekis, Konstantinos Kalafatakis & Konstantinos Kostikas. (2021) The present and future of inhalation therapy for
the management of obstructive airway diseases:
Emphasis on pressurized metered-dose inhalers. Pneumon, pages 1-13.
Crossref
Crossref
Maarten van den Berge, Jan De Backer, Cedric Van Holsbeke, Wilfried De Backer, Roopa Trivedi, Martin Jenkins, Paul Dorinsky & Magnus Aurivillius. (2021) Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids. Respiratory Research 22:1.
Crossref
Crossref
Omar S. Usmani, Rajiv Dhand, Federico Lavorini & David Price. (2021) Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease. Mayo Clinic Proceedings 96:9, pages 2448-2463.
Crossref
Crossref
S. N. Avdeev & N. V. Trushenko. (2021) New triple combination of beclomethasone dipropionate, glycopyrronium bromide and formoterol fumarate in the treatment of chronic obstructive pulmonary disease. PULMONOLOGIYA 31:3, pages 365-373.
Crossref
Crossref